| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.56 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.16 | 0.3 |